Sikkerhed og effekt af administration af Neupopeg hos de novo AML- patienter < 55 år med cytogenetik t( 15; 17) er ikke fastslået.
ed The safety and efficacy of Neupopeg administration in de novo AML patients aged < 55 years with cytogenetics t(15; 17) have not been established.